S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

实时更新: Johnson & Johnson [JNJ.DE]

交易所: XETRA 部门: Pharmaceuticals 工业: Drug Manufacturers—General
最后更新时间26 Apr 2024 @ 23:35

0.15% 137.20

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 23:35):

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide...

Stats
今日成交量 4 839.00
平均成交量 3 176.00
市值 330.62B
EPS €0 ( 2024-04-15 )
下一个收益日期 ( €0 ) 2024-07-16
Last Dividend €1.190 ( 2023-08-25 )
Next Dividend €0 ( N/A )
P/E 19.74
ATR14 €0.125 (0.09%)

音量 相关性

長: -0.05 (neutral)
短: -0.75 (moderate negative)
Signal:(64.235) Neutral

Johnson & Johnson 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Johnson & Johnson 相关性 - 货币/商品

The country flag -0.41
( neutral )
The country flag -0.30
( neutral )
The country flag 0.00
( neutral )
The country flag -0.40
( neutral )
The country flag -0.39
( neutral )
The country flag 0.00
( neutral )

Johnson & Johnson 财务报表

Annual 2023
营收: €85.16B
毛利润: €58.61B (68.82 %)
EPS: €13.88
FY 2023
营收: €85.16B
毛利润: €58.61B (68.82 %)
EPS: €13.88
FY 2022
营收: €94.94B
毛利润: €63.85B (67.26 %)
EPS: €6.86
FY 2021
营收: €93.78B
毛利润: €63.92B (68.16 %)
EPS: €7.93

Financial Reports:

No articles found.

Johnson & Johnson Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€1.130
(N/A)
€1.130
(N/A)
€1.130
(N/A)
€1.190
(N/A)
€1.190
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

Johnson & Johnson Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 3.76 - low (25.10%) | Divividend Growth Potential Score: 5.82 - Stable (16.47%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €0.415 2008-02-22
Last Dividend €1.190 2023-08-25
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 65 --
Total Paid Out €56.18 --
Avg. Dividend % Per Year 0.00% --
Score 3.59 --
Div. Sustainability Score 3.76
Div.Growth Potential Score 5.82
Div. Directional Score 4.79 --
Next Divdend (Est)
(2024-07-01)
€1.211 Estimate 22.50 %
Dividend Stability
0.60 Above Average
Dividend Score
3.59
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
KLA.DE Ex Dividend Knight 2023-08-14 Quarterly 0 0.00%
TOTB.DE Ex Dividend King 2024-01-02 Quarterly 0 0.00%
DWNI.DE Ex Dividend Junior 2023-06-16 Annually 0 0.00%
MUM.DE Ex Dividend Knight 2023-05-12 Annually 0 0.00%
ACT.DE Ex Dividend Knight 2023-05-12 Annually 0 0.00%
WMT.DE Ex Dividend Knight 2023-12-07 Quarterly 0 0.00%
FQT.DE Ex Dividend Knight 2023-06-05 Annually 0 0.00%
PCG6.F Ex Dividend Junior 2023-07-28 Quarterly 0 0.00%
BAS.DE Ex Dividend Knight 2023-04-28 Annually 0 0.00%
HLE.DE Ex Dividend Knight 2023-05-02 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.4531.5000.9491.424[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.5721.5004.767.14[0.1 - 1]
payoutRatioTTM0.218-1.0007.82-7.82[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM44.511.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM8.032.007.3210.00[0 - 30]
freeCashFlowPerShareTTM6.322.006.8410.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.6871.0001.8901.890[0.2 - 0.8]
operatingProfitMarginTTM0.2731.0006.546.54[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score3.76

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM8.801.0009.210[1 - 100]
returnOnEquityTTM0.5722.506.637.14[0.1 - 1.5]
freeCashFlowPerShareTTM6.322.007.8910.00[0 - 30]
dividendYielPercentageTTM3.241.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM8.032.007.3210.00[0 - 30]
payoutRatioTTM0.2181.5007.82-7.82[0 - 1]
pegRatioTTM-0.3031.500-5.350[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2181.0007.050[0.1 - 0.5]
Total Score5.82

Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。